Curis (CRIS) Earnings Date & Reports

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CRIS is expected to report earnings to rise 20.65% to -484 cents per share on November 11

Q3'26

Est.

$-4.85

Q2'26

Beat

by $4.23

Q1'26

Missed

by $14.40

Q4'25

Beat

by $2.00

Q3'25

Beat

by $0.82

The last earnings report on August 24 showed earnings per share of -401 cents, beating the estimate of -825 cents. With 79.68K shares outstanding, the current market capitalization sits at 3.83M.

View a ticker or compare two or three

CRIS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days